Raleigh Capital Management Inc. Novartis Ag Transaction History
Raleigh Capital Management Inc.
- $255 Million
- Q3 2024
A detailed history of Raleigh Capital Management Inc. transactions in Novartis Ag stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 52 shares of NVS stock, worth $5,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 52
-0.0%
Holding current value
$5,500
Previous $5,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
133MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.29 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.27 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$856 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$739 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$610 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $228B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...